艾媒咨询｜“妇炎洁广告营销”事件舆情监测报告

2022年5月，有网友发现，妇炎洁新品“玻尿酸玫瑰滋养洗液”的广告宣传图有污名化女性之嫌。该事件曝光后，妇炎洁登上了微博热搜，5月17日中午，网友们攻占了妇炎洁最新微博的评论区，质疑其广告侮辱女性。5月18号《中国妇女报》批妇炎洁：勿以低俗钻营，随后江西樟树市市场监督管理局对其进行调查。

艾媒咨询 | 2023年中国国潮美妆消费趋势洞察报告

iiMedia Research（艾媒咨询）数据显示，超七成消费者看好国潮美妆品牌发展。国潮美妆品牌迎合文化自信、文化创新的政策趋势，随着颜值经济的发展，国民消费能力及消费需求的提升，国内美妆品牌纷纷入局，国潮美妆行业发展前景广阔。

艾媒咨询|2021年中国医美机构市场竞争态势及企业营销模式分析报告

本报告研究涉及企业/品牌/案例：华韩整形，瑞丽医美，美莱整形，医思健康

数据显示，2016—2020年中国医美行业市场规模五年平均增长率为12.8%，与此同时，中国医美市场用户规模增长了4倍多。在人们生活水平的提升、年轻一代对医美的接受度的提高、政府监管层对医美行业的整治给医美消费者信心的提升的综合作用下，预计中国医美市场规模在2022年将达到2232亿元。随着医美产品及仪器技术水平提升、医美知识普及等，民众对整形美容的观念正在向积极态度转变，在整个行业扩张的过程中，轻医美的受众面广、门槛低、复购率高，更有可能提升市场整体渗透率，成为我国医美行业的主要增量市场。
According to the data, from 2016 to 2020, the five-year average growth rate of the market scale of China's medical and American industry was 12.8%. At the same time, the user scale of China's medical and American market increased by more than four times. Under the combined effect of the improvement of people's living standards, the improvement of the acceptance of medical beauty by the younger generation, the regulation of the medical beauty industry by the government regulators and the improvement of medical beauty consumer confidence, it is expected that the scale of China's medical beauty market will reach 223.2 billion yuan in 2022. With the improvement of the technical level of medical beauty products and instruments and the popularization of medical beauty knowledge, people's concept of plastic beauty is changing to a positive attitude. In the process of the expansion of the whole industry, light medical beauty has a wide audience, low threshold and high repurchase rate, which is more likely to improve the overall penetration rate of the market and become the main incremental market of China's medical beauty industry.

艾媒咨询|2020上半年中国医疗美容行业趋势研究报告

本报告研究涉及企业/品牌/案例：美团医美、新氧。

受颜值经济影响，医疗美容市场异常火热，自2013年以来，中国医疗美容市场规模便保持持续增长趋势，预计2020年中国医疗美容用户规模达1520万人。随着医美消费意识的进一步觉醒、供给的持续增长和“互联网+医美”模式的渗透，未来医美行业的用户规模将继续增长。iiMedia Research（艾媒咨询）调研数据显示，六成用户理解支持医美消费，而目前线下医美机构仍然是消费者获取医美信息的主要渠道，其次是网络社交平台以及互联网医美平台。互联网医美平台的渗透率提升及内容化趋势，将有效推动行业资源的进一步整合，专业医美平台未来或将成为消费者了解及鉴别医美信息的重要窗口。美团医美、新氧等互联网医疗美容平台为医美行业新生态建设起到推动作用。互联网医疗美容平台的出现，以其低廉的佣金和可靠的垂直搜索特性在一定程度上帮助医美行业吸引更多消费者，拓展了获客渠道。未来医美机构将更加注重调整自身的营销策略，借助互联网平台等新手段更加精准的进行用户挖掘和服务扩散。

Affected by the beauty economy, the medical beauty market is extremely hot. Since 2013, the size of China's medical beauty market has maintained a continuous growth trend. It is estimated that the number of Chinese medical beauty users will reach 15.2 million in 2020. With the further awakening of medical aesthetics consumption awareness, continuous growth in supply and the penetration of the "Internet and medical aesthetics" model, the user scale of the medical aesthetics industry will continue to grow in the future. As the data of iiMedia Research showed, Sixty percent of users understand that they support the consumption of medical beauty, and offline medical beauty institutions are still the main channels for consumers to obtain medical beauty information, followed by online social platforms and Internet medical beauty platforms. The penetration rate and content trend of Internet medical aesthetics platforms will effectively promote the further integration of industry resources. In the future, professional medical aesthetics platforms may become an important window for consumers to understand and identify medical aesthetics information. Internet medical cosmetology platforms such as Meituan Medical Beauty and So Young have played a role in promoting the construction of a new ecology in the medical cosmetology industry. The emergence of the Internet medical cosmetology platform, with its low commissions and reliable vertical search features, has helped the medical cosmetology industry to attract more consumers to a certain extent and expanded the customer acquisition channels. In the future, medical aesthetic institutions will pay more attention to adjusting their own marketing strategies, and accurately conduct user data mining and service diffusion.

2018广东互联网大会演讲PPT|建构健康内容生态 推动内容价值回归|阿里巴巴UC

2018广东互联网大会-建构健康内容生态 推动内容价值回归-杨锋

艾媒咨询|2021年中国养生美容市场研究报告

2021年9月4日，“2021CIBE中国养生美容大会”将在广州•广交会展馆举办。大会以“养生•美容”为主题，从养生行业的发展现状及未来趋势出发，探索养生与美容行业间的平衡，挖掘养生美容高级且特色的项目，拓宽美业增量赛道的选择，构建养生美容的全渠道触点，汇聚平台、品牌、优质连锁、行业专家等嘉宾共同探讨推动行业的发展与进步。如今美业的竞争不仅是产品服务的竞争，更是大数据的比拼。艾媒咨询CEO兼首席分析师张毅受邀出席本次大会并将现场发布《2021年中国养生美容市场研究报告》，将利用艾媒大数据决策和智能分析系统的数据挖掘结果，洞察消费者需求和中国养生美容市场现状。
On September 4, 2021, "2021cibe China Health and beauty conference" will be held in the exhibition hall of Guangzhou • Canton Fair. With the theme of "health preservation and beauty", starting from the development status and future trend of the health preservation industry, the conference explores the balance between health preservation and beauty industry, excavates advanced and characteristic projects of health preservation and beauty, widens the choice of incremental tracks of the beauty industry, constructs all-channel contacts of health preservation and beauty, and gathers platforms, brands, high-quality chains Industry experts and other guests discussed and promoted the development and progress of the industry.Today, the competition of the US industry is not only the competition of products and services, but also the competition of big data. Zhang Yi, CEO and chief analyst of AI media consulting, was invited to attend the conference and will release the Research Report on China's health and beauty market in 2021. He will use the data mining results of AI media's big data decision-making and intelligent analysis system to gain insight into consumer demand and the current situation of China's health and beauty market.

艾媒咨询|2021年中国轻医美行业研究及产业链分析报告

本报告研究涉及企业/品牌/案例：爱美客，华熙生物，奇致激光，华韩整形，新氧，兰州生物

数据显示，2020年中国轻医美用户市场规模达到1520万人，预计到2021年将增至1813万人。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展，预计2021年中国轻医美市场将达到798亿元，同比增长46.4%。在行业快速增长的同时，轻医美产业链各环节企业由于集中度不同导致利润分配不均，具体来看，上游原料耗材企业由于高技术壁垒，市场集中度较高，毛利率高于中下游企业，如知名玻尿酸、肉毒素产品制造企业爱美客、华熙生物等，而中下游由于竞争分散，单体获利参差不齐，更容易产生乱象。但总体来说，在行业监管加强、机构自律、平台监督等多方力量共同作用下，轻医美行业将会向线上化、品牌化、规范化发展。
According to the data, the market size of China's light medical beauty users will reach 15.2 million in 2020, and it is expected to increase to 18.13 million by 2021. Driven by the awakening of consumer awareness and consumer demand, institutions and doctors strongly boost the rapid development of light medical beauty industry in the supply side. It is estimated that China's light medical beauty market will reach 79.8 billion yuan in 2021, with a year-on-year growth of 46.4%. With the rapid growth of the industry, the profit distribution of enterprises in each link of the light medical beauty industry chain is uneven due to different concentration. Specifically, due to high technical barriers, the upstream raw materials and consumables enterprises have higher market concentration and higher gross profit rate than the middle and downstream enterprises, such as the well-known hyaluronic acid, botulinum toxin product manufacturing enterprises aimekke, Huaxi biology, etc., while the middle and downstream enterprises have higher gross profit rate due to scattered competition, Individual profit is uneven, more likely to produce chaos. But on the whole, under the joint action of industry supervision, institutional self-discipline, platform supervision and other forces, the light medical beauty industry will develop to online, brand and standardization.

艾媒报告|2019年中国轻医美消费趋势研究报告

本报告研究涉及企业/品牌/案例：飞顿医疗激光公司，奇致激光，Lumenis，CANDELA，华西生物，Allergan，昊海生物科技，中国生物兰州生物制品研究所有限责任公司，上海九院，北京八大处，四川华西，小红书，百度，微信，新氧，更美，悦美，美团，阿里健康

当前，中国轻医美市场供需迎来双增长，轻医美市场逐渐崛起。iiMedia Research(艾媒咨询)数据显示，预计2020年中国轻医美市场用户规模将达到1520万人。便捷、安全成轻医美消费重要推力，随着轻医美消费意识日益提升，轻医美或成中国消费者求美的“第一选择”。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展。医美机构加速拓展轻医美业务，轻医美诊所应运而生。与此同时，轻医美医生在流程操作、药械使用上更易实现规模化培养。在行业支持体系方面，互联网医美平台助推轻医美加速数字化升级，市场管理提效规范行业发展。在此背景下，中国轻医美消费市场迎来更好的发展空间。纵观当前中国轻医美消费新态势，供需协同并进以及行业支持体系日益完善，轻医美消费已逐渐成为求美新主流。

At present, the supply and demand of China's light medical beauty market is experiencing double growth, and the light medical beauty market is gradually rising. According to iiMedia Research, it is estimated that the user scale of China's light medical beauty market will reach 15.2 million in 2020. Convenience and safety have become an important driving force for the consumption of light medical beauty. With the increasing consumer awareness of light medical beauty, light medical beauty or become the “first choice“ for Chinese consumers seeking beauty. Driven by the awakening of consumer consciousness and consumer demand, institutions and doctors have strongly boosted the rapid development of the light medical beauty industry on the supply side. Medical beauty institutions to accelerate the expansion of light medical beauty business, light medical beauty clinic came into being. At the same time, it is easier for doctors to realize large-scale cultivation in process operation and medical device use. In terms of the industry support system, the Internet medical beauty platform promotes the digitalization and upgrading of medical beauty, and market management improves the efficiency and standardizes the development of the industry. In this context, China's light medical beauty consumer market usher in a better space for development. In view of the new trend of China's light medical beauty consumption, the coordinated development of supply and demand and the increasingly perfect industry support system, light medical beauty consumption has gradually become the new mainstream of seeking beauty.

艾媒报告 |2018-2019中国医疗美容行业研究与产业链分析报告

本报告研究涉及企业/品牌包括:新氧、更美、悦美、美黛拉、美丽神器、美呗、南方医院、伊美尔、熙朵、碧莲盛、雍禾植发、科发源植发、新生植发、恒博医疗、昊海生物科技、华熙生物、复星医药、深圳鹏爱医疗美容医院、北京丽都医疗美容医院

中国医疗美容行业处于快速发展期，iiMedia Research（艾媒咨询）监测发现，2018年中国医美行业市场规模达2245亿元，牙齿美容及面部美容是医美市场的重要构成部分，占比分别达32.5%和35.3%。目前中国医美行业已形成生产商、医美机构、终端市场三大产业链环节，产业发展前景广阔，但作为新兴行业，中国医疗美容行业将面临着行业监管、公共关系危机、行业竞争激烈等几大风险。

Driven by the rise of the younger generation of consumer groups and the development of new models in the medical beauty industry, the penetration rate and consumer demand of China's medical beauty industry continue to rise. In 2018, the penetration rate of Chinese medical users reached 7.4%, and women were the main medical and aesthetic consumers. The proportion is 88.9%. At present, there are more than 10,000 registered medical and beauty institutions in China, and the industry is in a period of rapid development. iiMedia Research found that embedding, double eyelids, and full body fat filling are the favorite surgical items for Chinese women and medical consumers, while nasal synthesis, tautological fat, cheeks, hair transplants, etc. For the Chinese male medical beauty consumer's favorite surgical project, potential customers in China's medical beauty industry are most concerned about the safety of surgery, followed by medical qualifications and word of mouth and surgery prices. Medical beauty as an emerging industry, public relations crisis, strict industry supervision, lack of relevant professionals is a factor that restricts its development, and in the future, with the influx of capital from the industry, the competition in China's medical and aesthetic industry will become more intense.

艾媒咨询 | 2025年中国医美行业发展状况与消费行为调查数据

随着消费升级与技术迭代，中国医美行业已从传统整形扩展至轻医美、抗衰老等多元化领域，市场规模持续扩大。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国医美行业发展状况与消费行为调查数据》显示，2025年中国医美服务行业市场规模为3701亿元，2025年中国轻医美市场用户规模达3105万人。中国医美市场的增长不仅源于消费升级，也得益于技术普惠与轻医美项目的高复购率。当前行业已进入以精细化运营、差异化服务和合规化发展为核心驱动的新阶段。
在2025年中国消费者对医美项目的接受程度中，“会考虑整形，但风险要相对可控”位列第一，占比46.02%；其次是“能够接受手术医美整形，并承受一定风险”，占比22.94%。此外，在消费者接受过的医美项目中，轻医美（非手术类）占比最高，达到74.45%；医美整形（手术类）的占比为33.52%。这表明中国消费者对医美的态度趋于理性与谨慎，安全可控的非手术类项目成为市场主流偏好。同时，手术类项目亦拥有稳定的需求群体，显示出市场需求的层次性与多元化。
艾媒咨询分析师认为，未来中国医美市场将延续“轻医美主导、技术驱动、合规深化”的主线发展。一方面，非手术项目凭借低风险、高复购优势，仍是增长核心，Z世代与男性、下沉市场需求进一步释放。另一方面，再生材料、AI个性化方案及智能器械加速迭代，推动服务精准化与效果革新。此外，监管常态化下，行业加速品牌化整合，合规机构与上游技术型企业凸显优势。总的来说，消费者更趋理性，追求自然效果与安全保障，倒逼市场从营销竞争转向以品质、精细化运营为核心的高质量发展新阶段。
With the upgrading of consumption and technological advancements, China's medical aesthetics industry has expanded from traditional plastic surgery to diversified fields such as minimally invasive aesthetics and anti-aging. The market size has continued to grow. According to the latest "2025 China Medical Aesthetics Industry Development Status and Consumer Behavior Survey Data" released by iiMedia Research, a leading third-party data mining and analysis institution for the new economy industry, the market size of China's medical aesthetics service industry will reach 370.1 billion yuan in 2025, and the user scale of the minimally invasive aesthetics market in China will reach 31.05 million people in 2025. The growth of China's medical aesthetics market is not only due to the upgrading of consumption but also benefits from the popularization of technology and the high repurchase rate of minimally invasive aesthetics projects. Currently, the industry has entered a new stage driven by refined operation, differentiated services, and compliance development.
In terms of Chinese consumers' acceptance of medical aesthetics projects in 2025, "Would consider plastic surgery, but the risk should be relatively controllable" ranks first, accounting for 46.02%; followed by "Can accept surgical medical aesthetics and bear certain risks", accounting for 22.94%. Additionally, among the medical aesthetics projects consumers have received, minimally invasive aesthetics (non-surgical) accounts for the highest proportion, reaching 74.45%; surgical medical aesthetics accounts for 33.52%. This indicates that Chinese consumers' attitudes towards medical aesthetics are becoming more rational and cautious, and non-surgical projects with low risks and high repurchase rates have become the mainstream preference in the market. At the same time, surgical projects also have a stable demand group, demonstrating the hierarchical and diversified nature of market demand.
Analysts from iiMedia Research believe that in the future, China's medical aesthetics market will continue to develop along the main line of "minimally invasive aesthetics dominance, technology-driven, and compliance deepening". On the one hand, non-surgical projects, with their low-risk and high-repurchase advantages, will remain the core of growth, and the demands of Generation Z, men, and consumers in lower-tier cities will be further released. On the other hand, regenerative materials, AI personalized solutions, and intelligent devices will accelerate iteration, promoting the precision and effect innovation of services. Moreover, under the normalization of regulation, the industry will accelerate brand integration, and compliant institutions and upstream technology enterprises will highlight their advantages. In summary, consumers are becoming more rational, pursuing natural effects and safety guarantees, which will force the market to shift from marketing competition to high-quality development centered on quality and refined operation.